2005
DOI: 10.1111/j.1468-1331.2005.01197.x
|View full text |Cite
|
Sign up to set email alerts
|

Cost of Parkinson's disease in Europe

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
24
1
5

Year Published

2006
2006
2014
2014

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(31 citation statements)
references
References 29 publications
1
24
1
5
Order By: Relevance
“…It is currently considered the second most common neurodegenerative disease worldwide, affecting approximately 1% of the world population over 65 years of age 2 . The socioeconomic impact of PD on health services is high 3 , being needed interventions which assist in the treatment of PD. The drug intervention is still the main form of PD treatment 4 .…”
Section: Introductionmentioning
confidence: 99%
“…It is currently considered the second most common neurodegenerative disease worldwide, affecting approximately 1% of the world population over 65 years of age 2 . The socioeconomic impact of PD on health services is high 3 , being needed interventions which assist in the treatment of PD. The drug intervention is still the main form of PD treatment 4 .…”
Section: Introductionmentioning
confidence: 99%
“…Parkinson's disease (PD) is the second most common age-related neurological disorder, affecting ϳ1% of people over 65 years old and 4 -5% of people over 85, and thus is considered as a major social health problem with significant economic impact (Tanner and Goldman, 1996;Lindgren et al, 2005;Dorsey et al, 2007). The disease is characterized by a progressive loss of dopamine (DA)-producing neurons in the midbrain, which results in a decline of DA innervation of the major forebrain terminal field, the striatum (Kish et al, 1988;Fearnley and Lees, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…The published literature about PD costs also reflects that following the pattern presented by Andlin-Sobocki et al as this is a costly disease with remarkable pressures on either the patient and the society and in general terms, the progression of the disease leads to higher costs [238]. As it was already stated, measuring accurately the cost of a specific disease is not a simple task, neither the aggregation of different already available cost studies nor the comparison of their results.…”
Section:  Fixed Costsmentioning
confidence: 95%
“…The largest non-medical resource component was cost of social services, €52 billion (13% of total cost) also closely related with the informal care. It refers to the unpaid care provided by family members, friends or voluntary workers to disabled and impaired individuals in the community [238]. The indirect cost was estimated to €179 billion, 46% of the total cost.…”
Section:  Fixed Costsmentioning
confidence: 99%
See 1 more Smart Citation